We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Siemens and Biosense Webster Extend Catheter Distribution Agreement

By MedImaging staff writers
Posted on 02 Feb 2007
Siemens Medical Solutions (Erlangen, Germany) and Biosense Webster, Inc. More...
(Diamond Bar, CA, USA) announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' Acuson AcuNav ultrasound catheters to interventional cardiologists.

Earlier in 2007, Biosense Webster was granted exclusive distribution rights to market the catheter to electrophysiologists. The Siemens AcuNav ultrasound catheters provide physicians with high-quality diagnostic images and Doppler blood flow data throughout the entire heart during a cardiac catheterization procedure. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products, will help physicians improve care for the cardiac patient,” said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center (New York, NY, USA). "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community.”

Biosense Webster is a major player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader. This expanded strategic alliance will enable both two companies to address the real-time imaging needs of interventional cardiologists.

"We are pleased to extend this strategic alliance with Siemens Medical Solutions Ultrasound Division into the interventional cardiology market. This agreement provides additional opportunities to collaborate with our partners at Siemens to bring to market innovative solutions in electrophysiology and interventional cardiology,” said Roy Tanaka, president, Biosense Webster. "Together, Biosense Webster and Siemens will better serve the needs of cardiologists around the world to help millions of patients each year who suffer from cardiovascular disease.”

Biosense Webster pioneered electrophysiology diagnostic catheters more than 30 years ago and continues to provide advanced diagnostic, therapeutic, and mapping tools.



Related Links:
Siemens Medical Solutions
Biosense Webster

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Reusable catheter patients used 35 percent fewer antibiotics compared to their single-use only counterparts. (Photo courtesy of the University of Southampton)

Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections

Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more

Surgical Techniques

view channel
Image: Avvio Medical\'s technology combines microbubble-enhanced acoustic cavitation with smart catheter navigation to precisely target and break down ureteral stones, all without the need for routine stenting or general anesthesia (Photo courtesy of Avvio Medical)

Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment

Ureteral stone care is often delayed by operating room scheduling constraints and growing wait times, leaving a gap between diagnosis and treatment. With no fundamentally new therapeutic approach introduced... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.